Effect Of Dexmedetomidine Infusion On Sublingual Microcirculation In Patients Undergoing On Pump Coronary Artery Bypass Graft Surgery

Trial Profile

Effect Of Dexmedetomidine Infusion On Sublingual Microcirculation In Patients Undergoing On Pump Coronary Artery Bypass Graft Surgery

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs Dexmedetomidine (Primary) ; Propofol
  • Indications Sedation
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Sep 2017 Planned number of patients changed from 68 to 70.
    • 18 Sep 2017 Planned End Date changed from 1 Jan 2017 to 1 Oct 2017.
    • 18 Sep 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top